Literature DB >> 26491151

γδ T Cells Play a Protective Role in Chikungunya Virus-Induced Disease.

Kristin M Long1, Martin T Ferris2, Alan C Whitmore2, Stephanie A Montgomery3, Lance R Thurlow4, Charles E McGee2, Carlos A Rodriguez5, Jean K Lim5, Mark T Heise6.   

Abstract

UNLABELLED: Chikungunya virus (CHIKV) is an alphavirus responsible for causing epidemic outbreaks of polyarthralgia in humans. Because CHIKV is initially introduced via the skin, where γδ T cells are prevalent, we evaluated the response of these cells to CHIKV infection. CHIKV infection led to a significant increase in γδ T cells in the infected foot and draining lymph node that was associated with the production of proinflammatory cytokines and chemokines in C57BL/6J mice. γδ T cell(-/-) mice demonstrated exacerbated CHIKV disease characterized by less weight gain and greater foot swelling than occurred in wild-type mice, as well as a transient increase in monocytes and altered cytokine/chemokine expression in the foot. Histologically, γδ T cell(-/-) mice had increased inflammation-mediated oxidative damage in the ipsilateral foot and ankle joint compared to wild-type mice which was independent of differences in CHIKV replication. These results suggest that γδ T cells play a protective role in limiting the CHIKV-induced inflammatory response and subsequent tissue and joint damage. IMPORTANCE: Recent epidemics, including the 2004 to 2007 outbreak and the spread of CHIKV to naive populations in the Caribbean and Central and South America with resultant cases imported into the United States, have highlighted the capacity of CHIKV to cause explosive epidemics where the virus can spread to millions of people and rapidly move into new areas. These studies identified γδ T cells as important to both recruitment of key inflammatory cell populations and dampening the tissue injury due to oxidative stress. Given the importance of these cells in the early response to CHIKV, this information may inform the development of CHIKV vaccines and therapeutics.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26491151      PMCID: PMC4702549          DOI: 10.1128/JVI.02159-15

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  106 in total

Review 1.  Role of γδ T cells in West Nile virus-induced encephalitis: friend or foe?

Authors:  Tian Wang
Journal:  J Neuroimmunol       Date:  2011-11-10       Impact factor: 3.478

2.  Role of γδ T cells in antibody production and recovery from SFV demyelinating disease.

Authors:  Farinaz Safavi; Jason P Feliberti; Cedric S Raine; Foroozan Mokhtarian
Journal:  J Neuroimmunol       Date:  2011-05-25       Impact factor: 3.478

3.  Vectors of Chikungunya virus in Senegal: current data and transmission cycles.

Authors:  M Diallo; J Thonnon; M Traore-Lamizana; D Fontenille
Journal:  Am J Trop Med Hyg       Date:  1999-02       Impact factor: 2.345

4.  Type I IFN controls chikungunya virus via its action on nonhematopoietic cells.

Authors:  Clémentine Schilte; Thérèse Couderc; Fabrice Chretien; Marion Sourisseau; Nicolas Gangneux; Florence Guivel-Benhassine; Anton Kraxner; Jürg Tschopp; Stephen Higgs; Alain Michault; Fernando Arenzana-Seisdedos; Marco Colonna; Lucie Peduto; Olivier Schwartz; Marc Lecuit; Matthew L Albert
Journal:  J Exp Med       Date:  2010-02-01       Impact factor: 14.307

5.  Chronic joint disease caused by persistent Chikungunya virus infection is controlled by the adaptive immune response.

Authors:  David W Hawman; Kristina A Stoermer; Stephanie A Montgomery; Pankaj Pal; Lauren Oko; Michael S Diamond; Thomas E Morrison
Journal:  J Virol       Date:  2013-10-16       Impact factor: 5.103

6.  Chikungunya infection in travelers.

Authors:  Patrick Hochedez; Stephane Jaureguiberry; Monique Debruyne; Philippe Bossi; Pierre Hausfater; Gilles Brucker; Francois Bricaire; Eric Caumes
Journal:  Emerg Infect Dis       Date:  2006-10       Impact factor: 6.883

7.  Novel chikungunya virus variant in travelers returning from Indian Ocean islands.

Authors:  Philippe Parola; Xavier de Lamballerie; Jacques Jourdan; Clarisse Rovery; Véronique Vaillant; Philippe Minodier; Philippe Brouqui; Antoine Flahault; Didier Raoult; Rémi N Charrel
Journal:  Emerg Infect Dis       Date:  2006-10       Impact factor: 6.883

Review 8.  Chikungunya disease: infection-associated markers from the acute to the chronic phase of arbovirus-induced arthralgia.

Authors:  Laurence Dupuis-Maguiraga; Marion Noret; Sonia Brun; Roger Le Grand; Gabriel Gras; Pierre Roques
Journal:  PLoS Negl Trop Dis       Date:  2012-03-27

9.  Impact of Chikungunya virus infection on health status and quality of life: a retrospective cohort study.

Authors:  Man-Koumba Soumahoro; Patrick Gérardin; Pierre-Yves Boëlle; Joelle Perrau; Adrian Fianu; Jacques Pouchot; Denis Malvy; Antoine Flahault; François Favier; Thomas Hanslik
Journal:  PLoS One       Date:  2009-11-11       Impact factor: 3.240

10.  Post-epidemic Chikungunya disease on Reunion Island: course of rheumatic manifestations and associated factors over a 15-month period.

Authors:  Daouda Sissoko; Denis Malvy; Khaled Ezzedine; Philippe Renault; Frederic Moscetti; Martine Ledrans; Vincent Pierre
Journal:  PLoS Negl Trop Dis       Date:  2009-03-10
View more
  17 in total

1.  Immunopathogenesis of alphaviruses.

Authors:  Victoria K Baxter; Mark T Heise
Journal:  Adv Virus Res       Date:  2020-07-08       Impact factor: 9.937

Review 2.  Chikungunya virus: epidemiology, replication, disease mechanisms, and prospective intervention strategies.

Authors:  Laurie A Silva; Terence S Dermody
Journal:  J Clin Invest       Date:  2017-03-01       Impact factor: 14.808

Review 3.  Immune-Mediated Protection and Pathogenesis of Chikungunya Virus.

Authors:  Julie M Fox; Michael S Diamond
Journal:  J Immunol       Date:  2016-12-01       Impact factor: 5.422

4.  Naturally Existing Oncolytic Virus M1 Is Nonpathogenic for the Nonhuman Primates After Multiple Rounds of Repeated Intravenous Injections.

Authors:  Haipeng Zhang; Yuan Lin; Kai Li; Jiankai Liang; Xiao Xiao; Jing Cai; Yaqian Tan; Fan Xing; Jialuo Mai; Yuan Li; Wenli Chen; Longxiang Sheng; Jiayu Gu; Wenbo Zhu; Wei Yin; Pengxin Qiu; Xingwen Su; Bingzheng Lu; Xuyan Tian; Jinhui Liu; Wanjun Lu; Yunling Dou; Yijun Huang; Bing Hu; Zhuang Kang; Guangping Gao; Zixu Mao; Shi-Yuan Cheng; Ling Lu; Xue-Tao Bai; Shoufang Gong; Guangmei Yan; Jun Hu
Journal:  Hum Gene Ther       Date:  2016-06-13       Impact factor: 5.695

5.  A Critical Role for STING Signaling in Limiting Pathogenesis of Chikungunya Virus.

Authors:  Tingting Geng; Tao Lin; Duomeng Yang; Andrew G Harrison; Anthony T Vella; Erol Fikrig; Penghua Wang
Journal:  J Infect Dis       Date:  2021-06-15       Impact factor: 5.226

6.  Dysregulated TGF-β Production Underlies the Age-Related Vulnerability to Chikungunya Virus.

Authors:  Jennifer L Uhrlaub; Vesna Pulko; Victor R DeFilippis; Rebecca Broeckel; Daniel N Streblow; Gary D Coleman; Byung S Park; John F Lindo; Ivan Vickers; Joshua J Anzinger; Janko Nikolich-Žugich
Journal:  PLoS Pathog       Date:  2016-10-13       Impact factor: 6.823

7.  Disruption of the Opal Stop Codon Attenuates Chikungunya Virus-Induced Arthritis and Pathology.

Authors:  Jennifer E Jones; Kristin M Long; Alan C Whitmore; Wes Sanders; Lance R Thurlow; Julia A Brown; Clayton R Morrison; Heather Vincent; Kayla M Peck; Christian Browning; Nathaniel Moorman; Jean K Lim; Mark T Heise
Journal:  MBio       Date:  2017-11-14       Impact factor: 7.867

Review 8.  Tissue-Resident Innate and Innate-Like Lymphocyte Responses to Viral Infection.

Authors:  Andrew D Hildreth; Timothy E O'Sullivan
Journal:  Viruses       Date:  2019-03-19       Impact factor: 5.048

Review 9.  Genetic control of alphavirus pathogenesis.

Authors:  Victoria K Baxter; Mark T Heise
Journal:  Mamm Genome       Date:  2018-08-27       Impact factor: 2.957

Review 10.  Cellular and Molecular Immune Response to Chikungunya Virus Infection.

Authors:  Ithallo S B Tanabe; Eloiza L L Tanabe; Elane C Santos; Wanessa V Martins; Isadora M T C Araújo; Maria C A Cavalcante; Ana R V Lima; Niels O S Câmara; Leticia Anderson; Dinar Yunusov; Ênio J Bassi
Journal:  Front Cell Infect Microbiol       Date:  2018-10-10       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.